John Lewicki
Chief Tech/Sci/R&D Officer bei MEREO BIOPHARMA GROUP PLC
Vermögen: 2 402 $ am 31.03.2024
Profil
John A.
Lewicki is currently the Chief Scientific Officer at Mereo BioPharma Group Plc since 2020.
Prior to this, he worked at OncoMed Pharmaceuticals, Inc. as the President, Chief Executive Officer & Director from 2018 to 2019.
He also worked at Scios, Inc. as a Principal from 1983 to 2000.
Dr. Lewicki holds a doctorate degree from the University of California San Diego.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 25.01.2024 | 3 640 ( 0,00% ) | 2 402 $ | 31.03.2024 |
Aktive Positionen von John Lewicki
| Unternehmen | Position | Beginn |
|---|---|---|
| MEREO BIOPHARMA GROUP PLC | Chief Tech/Sci/R&D Officer | 01.07.2020 |
Ehemalige bekannte Positionen von John Lewicki
| Unternehmen | Position | Ende |
|---|---|---|
| ONCOMED PHARMACEUTICALS INC | Chief Executive Officer | 23.04.2019 |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von John Lewicki
| University of California San Diego | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| MEREO BIOPHARMA GROUP PLC | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Scios, Inc.
Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
OncoMed Pharmaceuticals, Inc.
 OncoMed Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OncoMed Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on discovering and developing novel therapeutics for cancer's growth, resistance, recurrence and metastasis. The company was founded by Michael F. Clarke and Max Wicha in August 2004 and is headquartered in Redwood City, CA. | Health Technology |
